| |
|
|
|
AcelRx Pharmaceuticals Inc.  
|
|
1.78 -0.16 (-0.08%) |
11-11 16:00 |
|
Open: |
1.88 |
Pre close: |
1.94 |
Target:
|
2.39 
|
|
High: |
1.9 |
Low: |
1.74 |
Resistance:
|
2.04
2.23
|
|
Volume: |
2,391,582 |
Market Cap: |
142M |
Support:
|
1.74
1.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.93
|
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
2.10 |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
2.34 |
Stochastic Oscillator |
%K(14,3):
|
23.77  |
|
MA(250): |
2.73 |
%D(3): |
23.81 |
|
Average Volume(K) |
3-Month: |
79602
|
52-Week |
High:
|
4.09 |
|
10-Days: |
155850 |
Low: |
1.74 |
|
RSI |
RSI(14):
|
26.88 |
Change(%): |
-45.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.669 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
79.44 |
|
EPS Est. Current Year |
-1.120 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
78.35 |
|
EPS Est. Next Year |
-0.940 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.62 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
61.3 |
% Held by Institutions |
19.73 |
|
Forward EPS |
-0.909 |
Gross Profit (p.s.) |
-0.188 |
Shares Short (K) |
14200 |
|
Book Value (p.s.) |
-0.230 |
EBITDA (p.s.) |
-0.615 |
P/E |
-2.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-7.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
59.33 |
|
Operating Margin |
-2067.99 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
